Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness

NCT01196442 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT01196442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01196442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Expanded Trial of MC5-A Calmare Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy Including Pain and Numbness
Lead sponsor
Virginia Commonwealth University
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2010
Completion date
January 31, 2013
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer-related problem/condition, neurotoxicity, pain, peripheral neuropathy